|
Index of reports
> Cases resulting in death (7)
> Cases with Breast Cancer (2)
Below is the selection of adverse event reports related to Estrace (Estradiol Vaginal) that includes cases resulting in death where reactions include breast cancer.
Adverse event in 59 year old female receiving Estrace (Estradiol Vaginal)
Reported by a consumer/non-health professional from United States on 2007-01-18
Patient: 59 year old female
Adverse reactions / side effects: Breast Cancer, Death
Adverse event resulted in: death
Suspect drug(s):
Estrace
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2004-01-01
Estrace
Indication: Osteoporosis
Start date: 1995-01-01
End date: 2004-01-01
Provera
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2004-01-01
Prometrium
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2004-01-01
Medroxyprogesterone
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2004-01-01
Estradiol
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2004-01-01
Adverse event in 59 year old female receiving Estrace (Estradiol Vaginal)
Reported by a lawyer from United States on 2007-01-12
Patient: 59 year old female
Adverse reactions / side effects: Breast Cancer
Adverse event resulted in: death
Suspect drug(s):
Provera
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1995-01-01
End date: 2004-01-01
Medroxyprogesterone
Indication: Hormone Replacement Therapy
Start date: 1995-01-01
End date: 2004-01-01
Estrace
Indication: Hormone Replacement Therapy
Start date: 1995-01-01
End date: 2004-01-01
Prometrium
Indication: Hormone Replacement Therapy
Start date: 1995-01-01
End date: 2004-01-01
Estradiol
Indication: Hormone Replacement Therapy
Start date: 1995-01-01
End date: 2004-01-01
|
